Amphastar Pharmaceuticals (AMPH) EBITDA Margin (QoQ) (2013 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) EBITDA Margin (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,364.00 |
| Mar 31, 2026 | -1,148.00 |
| Dec 31, 2025 | 625.00 |
| Sep 30, 2025 | -1,099.00 |
| Jun 30, 2025 | 232.00 |
| Mar 31, 2025 | -233.00 |
| Dec 31, 2024 | -563.00 |
| Sep 30, 2024 | -44.00 |
| Jun 30, 2024 | 233.00 |
| Mar 31, 2024 | -237.00 |
| Dec 31, 2023 | -994.00 |
| Sep 30, 2023 | 1,493.00 |
| Jun 30, 2023 | 144.00 |
| Mar 31, 2023 | -414.00 |
| Dec 31, 2022 | 868.00 |
| Sep 30, 2022 | -77.00 |
| Jun 30, 2022 | 215.00 |
| Mar 31, 2022 | -211.00 |
| Dec 31, 2021 | -201.00 |
| Sep 30, 2021 | 1,169.00 |